Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Current Opinion in Immunology
|
May 31, 2017
Editorial overview: Germinal centers and memory B-cells: from here to eternity
David Tarlinton, Gabriel Victora
Immunity
|
April 27, 2007
Antigen to the node: B cells go native
David Tarlinton, Andrew Lew
Clinical & Translational Immunology
|
April 15, 2024
Chimeric antigen receptor T cells in the fast lane among autoimmune disease therapies
Zhoujie Ding, David Tarlinton
Nature Immunology
|
October 21, 2022
Time is of the essence for vaccine success
Isaak Quast, David Tarlinton
Science (New York, N.Y.)
|
September 14, 2013
Diversity among memory B cells: origin, consequences, and utility
David Tarlinton, Kim Good-Jacobson
Trends in Molecular Medicine
|
November 28, 2016
HIV Vaccines: One Step Closer
Michael Sze Yuan Low, David Tarlinton
Current Opinion in Immunology
|
May 6, 2008
Plasma cell differentiation and survival
David Tarlinton, Andreas Radbruch, Falk Hiepe, et al.
Immunological Reviews
|
February 12, 2016
Targeting plasma cells: are we any closer to a panacea for diseases of antibody-secreting cells?
Michael Low, Simona Infantino, George Grigoriadis, et al.
Molecular and Cellular Biology
|
September 20, 2021
The ASCIZ-DYNLL1 Axis Is Essential for TLR4-Mediated Antibody Responses and NF-κB Pathway Activation
Rui Liu, Ashleigh King, David Tarlinton, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 19, 2003
Architectural defects in the spleens of Nkx2-3-deficient mice are intrinsic and associated with defects in both B cell maturation and T cell-dependent immune responses
David Tarlinton, Amanda Light, Donald Metcalf, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Current Opinion in Immunology
|
May 31, 2017
Editorial overview: Germinal centers and memory B-cells: from here to eternity
David Tarlinton, Gabriel Victora
Immunity
|
April 27, 2007
Antigen to the node: B cells go native
David Tarlinton, Andrew Lew
Clinical & Translational Immunology
|
April 15, 2024
Chimeric antigen receptor T cells in the fast lane among autoimmune disease therapies
Zhoujie Ding, David Tarlinton
Nature Immunology
|
October 21, 2022
Time is of the essence for vaccine success
Isaak Quast, David Tarlinton
Science (New York, N.Y.)
|
September 14, 2013
Diversity among memory B cells: origin, consequences, and utility
David Tarlinton, Kim Good-Jacobson
Trends in Molecular Medicine
|
November 28, 2016
HIV Vaccines: One Step Closer
Michael Sze Yuan Low, David Tarlinton
Current Opinion in Immunology
|
May 6, 2008
Plasma cell differentiation and survival
David Tarlinton, Andreas Radbruch, Falk Hiepe, et al.
Immunological Reviews
|
February 12, 2016
Targeting plasma cells: are we any closer to a panacea for diseases of antibody-secreting cells?
Michael Low, Simona Infantino, George Grigoriadis, et al.
Molecular and Cellular Biology
|
September 20, 2021
The ASCIZ-DYNLL1 Axis Is Essential for TLR4-Mediated Antibody Responses and NF-κB Pathway Activation
Rui Liu, Ashleigh King, David Tarlinton, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 19, 2003
Architectural defects in the spleens of Nkx2-3-deficient mice are intrinsic and associated with defects in both B cell maturation and T cell-dependent immune responses
David Tarlinton, Amanda Light, Donald Metcalf, et al.
Page
of 4